Breakthrough for IntelliCell BioSciences, Inc with Dr. Steven Victor

In recent news, IntelliCell BioSciences, Inc. just announced a study they had published regarding the efficacy of IntelliCell’s proprietary SVF for treating gum recession. This company, a leader in regenerative medicine and the manufacturing of stromal vascular fraction (SVF) that contains adipose derived adult stem cells, just published this pilot study on the October 2011 edition of the Journal of Implant & Advanced Clinical Dentistry.

Authored by Nicholas Toscano, DDS, MS; Danny Holtzclaw, DDS, MS; and Steven Victor, MD, the pilot study included 7 females and one male. They showed that Mucograft ® collagen matrix in combination with SVF treatments might be a clear alternative to invasive harvesting of gum tissue for gum recession.

As IntelliCell Chairman and CEO Dr. Steven Victor explained, “This is a very encouraging study. Gingival recession is a significant issue in dentistry and IntelliCell is offering a new, potentially superior, non-invasive solution that minimizes patient discomfort and improves outcomes. Dentistry is one of numerous fields in which our SVF may show efficacy.”

Dr. Nicholas Toscano, the periodontist who ran the study said, “I am really excited about stromal vascular fracture stem cells and the impact on regenerative dentistry. Future research could prove this to be a major breakthrough in oral and maxillofacial reconstruction.”